"0002-2980-26" National Drug Code (NDC)

NDC Code	0002-2980-26
Package Description	120 CAPSULE in 1 BOTTLE (0002-2980-26)
Product NDC	0002-2980
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Retevmo
Non-Proprietary Name	Selpercatinib
Dosage Form	CAPSULE
Usage	ORAL
Start Marketing Date	20200508
Marketing Category Name	NDA
Application Number	NDA213246
Manufacturer	Eli Lilly and Company
Substance Name	SELPERCATINIB
Strength	80
Strength Unit	mg/1
Pharmacy Classes	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Rearranged during Transfection (RET) Inhibitors [MoA]